Skip to main content
OpenTrials
Completed

NCT Number: NCT05853913

Acute Exercise on Brain Insulin Sensitivity

Dementia is a leading cause of death in the United States among aging adults. Brain insulin resistance has emerged as a pathologic factor affecting memory, executive function as well as systemic glucose control. Regular aerobic exercise decreases Alzheimer's Disease (AD) risk, in part, through changes in brain structure and function. However, there is limited data available on how exercise impacts brain insulin resistance in aging. This study will test the effect of acute exercise on brain insulin sensitivity in middle-aged to older adults. The study will also examine cognition and cardiometabolic health in relation to brain insulin sensitivity.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Institute for Food, Nutrition, and Health, New Brunswick, New Jersey, United States

Loading trial locations.

About this study

Obesity, hypertension, high blood glucose (e.g. prediabetes/type 2 diabetes), and physical inactivity is thought to worsen brain insulin resistance and reduce cerebral blood flow. This suggests lifestyle approaches may be necessary to counteract declines in brain health. Regular aerobic exercise decreases Alzheimer's Disease (AD) risk, in part, through changes in brain structure and function. Moreover, exercise-related structural changes in the brain, namely increased hippocampal volume, is linked to improved memory. However, there is limited data available on how exercise impacts brain insulin resistance in aging. It is also unclear if one bout of exercise may help improve brain insulin responses to insulin before fitness gains or weight loss in people at risk for dementia, type 2 diabetes and cardiovascular disease. Because single bouts of exercise are established to improve metabolic and vascular insulin sensitivity in people with obesity, the investigators anticipate exercise to raise brain insulin sensitivity in relation to cognition and cardiometabolic health.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female >/=40 and </=80 years old.
  • Has a body mass index >/=25 and </=45 kg/m2.
  • Physical Activity (<150 min of moderate/high intensity exercise per week)

Exclusion criteria

  • Subjects who have not been weight stable (>2 kg weight change in past 3 months)
  • Subjects who are smokers or who have quit smoking <1 years ago
  • Subjects with abnormal estimated glomerular filtration rate (eGFR).
  • Hypertriglyceridemic (>400 mg/dl) and hypercholesterolemic (>260 mg/dl) subjects
  • Hypertensive (>160/100 mmHg)
  • Subjects with a history of significant metabolic, cardiac, congestive heart failure, cerebrovascular, hematological, pulmonary, gastrointestinal, liver, renal, or endocrine disease or cancer that in the investigator's opinion would interfere with or alter the outcome measures or impact subject safety.
  • Pregnant (as evidenced by positive urine pregnancy test) or nursing women
  • Subjects with contraindications to participation in an exercise
  • Current Pregnancy
  • Currently taking active weight suppression medication (e.g. phentermine, orlistat, lorcaserin, naltrexone-bupropion in combination, liraglutide, benzphetamine, diethylpropion, phendimetrazine)
  • Subjects currently taking medications that affect heart rate and rhythm (i.e. Ca++ channel blockers, nitrates, alpha- or beta-blockers).
  • Known contraindications for MRI imaging

Treatment and study plan

Exercise

Behavioral

Exercise will be walking/jogging at a medium to hard intensity for 1 hour.

Primary outcomes

  1. Brain insulin sensitivity

    Time frame: Change from baseline to exercise; about 1 week apart

    MRI arterial spin labeling, cerebral blood flow

Secondary outcomes

  1. Cognition

    Time frame: Change from baseline to exercise; about 1 week apart

    NIH Toolbox Cognitive Battery

  2. Blood Glucose

    Time frame: Change from baseline to exercise; about 1 week apart

    Blood draw via oxidase method

  3. Blood Free Fatty Acids

    Time frame: Change from baseline to exercise; about 1 week apart

    Blood draw via colorimetric assays

  4. Carbohydrate Use

    Time frame: Change from baseline to exercise; about 1 week apart

    Indirect Calorimetry

  5. Systolic and Diastolic Blood Pressure

    Time frame: Change from baseline to exercise; about 1 week apart

    Cuff around arm

Sponsors and collaborators

Lead sponsor

Rutgers, The State University of New Jersey

Other

Registry information

Official study title

Impact of Acute Exercise on Brain Insulin Sensitivity in Middle-aged to Older Adults

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
May 11, 2023
Registry last updated
Nov 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.